세포 및 조직 보존 시장 : 세포 보존, 조직 보존, 보존 방법, 보존 장치, 보존제, 최종사용자별 - 세계 예측(2025-2030년)

The Cell & Tissue Preservation Market was valued at USD 12.48 billion in 2023, expected to reach USD 13.00 billion in 2024, and is projected to grow at a CAGR of 5.00%, to USD 17.57 billion by 2030.

The scope of the Cell & Tissue Preservation market encompasses the procedures, products, and technologies involved in maintaining cell and tissue integrity for extended periods, essential for research, transfusion, transplantation, and regenerative medicine. This market is driven by the necessity of preserving biological materials to ensure their viability and functionality during research, testing, and medical treatments. Applications are extensive, including biobanking, drug discovery, regenerative medicine, and bio-repositories, serving end-users like hospitals, research laboratories, and pharmaceutical companies. Key growth factors include the rising demand for regenerative medicine, advancements in biobanking, increasing investments in research and development, and the growing incidence of chronic diseases requiring innovative therapies.

The latest opportunities arise from technological innovations like cryopreservation, vitrification, and the development of novel cryoprotectants, which promise improved efficiency and reduced cellular damage. Companies can capitalize on strategic collaborations with research institutions for technology advancements and enter emerging markets where healthcare infrastructure is improving. However, the market faces limitations such as high costs of preservation equipment, lack of standardization in preservation techniques, and ethical concerns regarding the long-term storage of biological materials. Moreover, regulatory hurdles and the potential risks of sample contamination during storage present significant challenges.

Innovation areas with promising potential include cryobiology research to minimize cryoprotectant toxicity, development of automated systems for better preservation process management, and exploring alternative preservation techniques like anhydrobiosis. Businesses should focus on these innovation areas to enhance product offerings and achieve competitive advantage. The nature of the cell and tissue preservation market is dynamic, with a strong emphasis on technological advancements and strategic partnerships. Companies should prioritize innovation, regulatory compliance, and cost-effective solutions to harness lucrative opportunities in this vital segment, ensuring robust market positioning and sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell & Tissue Preservation Market

The Cell & Tissue Preservation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic diseases requiring long-term storage of biological samples for ongoing treatment
  • Technological integration in preservation systems improving efficiency and reliability
  • Growing trend towards personalized medicine requiring precise preservation of patient-specific cells and tissues
• Market Restraints
  • High costs of preservation techniques and equipment
• Market Opportunities
  • Government funding initiatives accelerating research in cell preservation methods
  • Revolutionary preservation solutions aimed at improving organ transplant success rates
  • Partnerships between biotech firms and research institutions advancing tissue preservation innovations
• Market Challenges
  • Issues regarding standardization and consistency of preservation methods

Porter's Five Forces: A Strategic Tool for Navigating the Cell & Tissue Preservation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell & Tissue Preservation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell & Tissue Preservation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell & Tissue Preservation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell & Tissue Preservation Market

A detailed market share analysis in the Cell & Tissue Preservation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell & Tissue Preservation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell & Tissue Preservation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell & Tissue Preservation Market

A strategic analysis of the Cell & Tissue Preservation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell & Tissue Preservation Market, highlighting leading vendors and their innovative profiles. These include Aldevron, LLC, Asymptote Ltd., Avantor, Inc., BioCision, LLC, BioLife Solutions, Inc., Biopharma Process Systems Ltd., Brooks Life Sciences, Charter Medical Ltd., Cryoport, Inc., CryoXtract Instruments, LLC, Custom Biogenic Systems, Inc., Lonza Group AG, MedCision LLC, MilliporeSigma, QIAGEN N.V., STEMBIOX, Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., VWR International, LLC, and Worthington Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell & Tissue Preservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Cell Preservation, market is studied across Application, End-User, and Type. The Application is further studied across Clinical Trials, Drug Development, and Regenerative Medicine. The End-User is further studied across Biobanks, Hospitals, Pharmaceutical Companies, and Research Laboratories. The Type is further studied across Long-Term Preservation and Short-Term Preservation.
• Based on Tissue Preservation, market is studied across Application, End-User, and Type. The Application is further studied across Biobanking, Clinical Research, and Organ Transplantation. The End-User is further studied across Diagnostic Centers, Research Institutions, and Transplant Centers. The Type is further studied across Cryopreservation and Hypothermic Preservation.
• Based on Preservation Methods, market is studied across Cryopreservation, Desiccation, and Hypothermic Preservation. The Cryopreservation is further studied across Slow Freezing and Vitrification.
• Based on Storage Equipment, market is studied across Accessories, Freezers, Refrigerators, and Storage Containers. The Accessories is further studied across Alarms and Monitoring Devices. The Freezers is further studied across Cryogenic Freezers, Mechanical Freezers, and Ultra-Low Temperature Freezers. The Storage Containers is further studied across Cryobags and Cryovials.
• Based on Preservation Agents, market is studied across Cryoprotectants and Hypothermic Preservation Solutions. The Cryoprotectants is further studied across Non-Penetrating Cryoprotectants and Penetrating Cryoprotectants.
• Based on End-Users, market is studied across Biobanks, Hospitals and Diagnostic Centers, and Research and Academic Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases requiring long-term storage of biological samples for ongoing treatment
    • 5.1.1.2. Technological integration in preservation systems improving efficiency and reliability
    • 5.1.1.3. Growing trend towards personalized medicine requiring precise preservation of patient-specific cells and tissues
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of preservation techniques and equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Government funding initiatives accelerating research in cell preservation methods
    • 5.1.3.2. Revolutionary preservation solutions aimed at improving organ transplant success rates
    • 5.1.3.3. Partnerships between biotech firms and research institutions advancing tissue preservation innovations
  • 5.1.4. Challenges
    • 5.1.4.1. Issues regarding standardization and consistency of preservation methods
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell & Tissue Preservation Market, by Cell Preservation

• 6.1. Introduction
• 6.2. Application
  • 6.2.1. Clinical Trials
  • 6.2.2. Drug Development
  • 6.2.3. Regenerative Medicine
• 6.3. End-User
  • 6.3.1. Biobanks
  • 6.3.2. Hospitals
  • 6.3.3. Pharmaceutical Companies
  • 6.3.4. Research Laboratories
• 6.4. Type
  • 6.4.1. Long-Term Preservation
  • 6.4.2. Short-Term Preservation

7. Cell & Tissue Preservation Market, by Tissue Preservation

• 7.1. Introduction
• 7.2. Application
  • 7.2.1. Biobanking
  • 7.2.2. Clinical Research
  • 7.2.3. Organ Transplantation
• 7.3. End-User
  • 7.3.1. Diagnostic Centers
  • 7.3.2. Research Institutions
  • 7.3.3. Transplant Centers
• 7.4. Type
  • 7.4.1. Cryopreservation
  • 7.4.2. Hypothermic Preservation

8. Cell & Tissue Preservation Market, by Preservation Methods

• 8.1. Introduction
• 8.2. Cryopreservation
  • 8.2.1. Slow Freezing
  • 8.2.2. Vitrification
• 8.3. Desiccation
• 8.4. Hypothermic Preservation

9. Cell & Tissue Preservation Market, by Storage Equipment

• 9.1. Introduction
• 9.2. Accessories
  • 9.2.1. Alarms
  • 9.2.2. Monitoring Devices
• 9.3. Freezers
  • 9.3.1. Cryogenic Freezers
  • 9.3.2. Mechanical Freezers
  • 9.3.3. Ultra-Low Temperature Freezers
• 9.4. Refrigerators
• 9.5. Storage Containers
  • 9.5.1. Cryobags
  • 9.5.2. Cryovials

10. Cell & Tissue Preservation Market, by Preservation Agents

• 10.1. Introduction
• 10.2. Cryoprotectants
  • 10.2.1. Non-Penetrating Cryoprotectants
  • 10.2.2. Penetrating Cryoprotectants
• 10.3. Hypothermic Preservation Solutions

11. Cell & Tissue Preservation Market, by End-Users

• 11.1. Introduction
• 11.2. Biobanks
• 11.3. Hospitals and Diagnostic Centers
• 11.4. Research and Academic Institutions

12. Americas Cell & Tissue Preservation Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Cell & Tissue Preservation Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Cell & Tissue Preservation Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aldevron, LLC
• 2. Asymptote Ltd.
• 3. Avantor, Inc.
• 4. BioCision, LLC
• 5. BioLife Solutions, Inc.
• 6. Biopharma Process Systems Ltd.
• 7. Brooks Life Sciences
• 8. Charter Medical Ltd.
• 9. Cryoport, Inc.
• 10. CryoXtract Instruments, LLC
• 11. Custom Biogenic Systems, Inc.
• 12. Lonza Group AG
• 13. MedCision LLC
• 14. MilliporeSigma
• 15. QIAGEN N.V.
• 16. STEMBIOX, Inc.
• 17. STEMCELL Technologies Inc.
• 18. Thermo Fisher Scientific Inc.
• 19. VWR International, LLC
• 20. Worthington Industries, Inc.